The difficulties in assessing the value of chemotherapeutic agents in such a disease as infantile gastroenteritis, of varied and as yet not thoroughly understood etiology, are not unexpected. The discovery of Escherichiaotypesserotypesth outbreaks of the illness has recently had its repercussions in the interpretation of the results of therapeutic trial of a new drug in infantile gastroenteritis. This has been so in the work of Alexander et k of on streptomycin in infantilycin in in.1 Again, the correlation of clinical ann of clinical and al Todd iol2.as thrown light on the variations in tw glight on ressases under chemotherogress of cases under chemotherapy, particularly receiving chloramg chicol.
In general, reports on the use of the latter antibiotic in the treatment and prophylaxis ofylaxis
ABOUL-DAHAB YW, TAWIL GS, EL-KHOLY S. Response of Infantile Gastroenteritis to Chloramphenicol: The Variability as Conditioned by the Spread of Resistant Strains of Serospecific Escherichia Coli O20. AMA Am J Dis Child. 1958;96(3):348–361. doi:10.1001/archpedi.1958.02060060350011
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: